KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Taxes (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Change in Taxes data on record, last reported at -$34.8 million in Q4 2025.

  • For Q4 2025, Change in Taxes changed 0.16% year-over-year to -$34.8 million; the TTM value through Dec 2025 reached $37.2 million, up 352.5%, while the annual FY2025 figure was $37.2 million, 352.5% up from the prior year.
  • Change in Taxes reached -$34.8 million in Q4 2025 per JAZZ's latest filing, down from $12.7 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $46.3 million in Q2 2025 and bottomed at -$46.5 million in Q2 2021.
  • Average Change in Taxes over 5 years is $1.5 million, with a median of $8.5 million recorded in 2022.
  • Peak YoY movement for Change in Taxes: plummeted 2264.41% in 2023, then soared 1359.08% in 2025.
  • A 5-year view of Change in Taxes shows it stood at -$24.7 million in 2021, then surged by 93.84% to -$1.5 million in 2022, then tumbled by 2264.41% to -$35.9 million in 2023, then grew by 3.06% to -$34.8 million in 2024, then rose by 0.16% to -$34.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Taxes were -$34.8 million in Q4 2025, $12.7 million in Q3 2025, and $46.3 million in Q2 2025.